Science6h ago
New, sophisticated drugs did not move the needs on hearts attacks, strokes: what this teaches us
AI EXECUTIVE SUMMARY
Drugs targeting hsCRP and Lp(a) biomarkers failed to lower heart attack and stroke rates in recent trials. These results reinforce that proven lifestyle changes—healthy diet, exercise, smoking cessation—remain the most effective prevention strategies. The findings highlight the limits of biomarker‑driven drug development for cardiovascular disease.
WHY IT MATTERS
The trials demonstrate that targeting hsCRP and Lp(a) biomarkers does not reduce cardiovascular events, underscoring the continued importance of proven lifestyle measures.
Drugs built against specific biomarkers hsCRP and Lp(a) both failed to reduce the number of heart attacks and strokes, in recent clinical trials. Cardiovascular medicine teaches us again and again that the interventions with the best evidence are still the boring ones: eat well, move, don’t smoke, stay lean
This story was originally reported by The Hindu — Science. As an automated real-time news aggregator, NewsToolBar provides multi-perspective indexing and AI summarization while directing full readership directly to primary publisher sources.
ALSO REPORTED BY OTHER SOURCES (2)
Saudi Arabia issues first air raid alerts for Riyadh since Houthis escalated attacks
Third Marineland beluga dies after move, this time in Spain
Community Sentiment & Coverage Reliability
Crowd-sourced evaluation based on verified reader feedback
Rate Coverage Tone:
No reader evaluations recorded yet — be the first to rate the coverage tone above!
Quick Story Reactions:
Community Discussion (0)
Join the Community Discussion
Sign in or create a free reader account to post comments, upvote analysis, and share your perspective.